Germany Genome Editing Market Size & Outlook, 2023-2030
Germany genome editing market, 2018-2030 (US$M)
Related Markets
Germany genome editing market highlights
- The Germany genome editing market generated a revenue of USD 311.3 million in 2023 and is expected to reach USD 1,007.2 million by 2030.
- The Germany market is expected to grow at a CAGR of 18.3% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 311.3 million |
| Market revenue in 2030 | USD 1,007.2 million |
| Growth rate | 18.3% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Germany accounted for 3.9% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 1,597.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 43.37% in 2023. Horizon Databook has segmented the Germany genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Germany generated significant revenue in the European genome editing market, which can be attributed to the presence of developed global companies, such as Merck KGaA & QIAGEN, which offer genome editing and related products.
The genome editing market is growing due to wide adoption of CRISPR genome editing technology for cell therapy to cure various diseases, boosting the country’s market. In March 2021, the country’s Federal Ministry of Education and Research allotted funding for research on CAR-T cell treatment for solid tumors.
In addition, the German genome editing market is expected to be fueled by conferences, meetings, and events regarding genome editing applications & limitations. For instance, in 2019, a project called Genome Editing in Societal Discourse was undertaken; this project aimed to increase public discussion on the legal, social, and ethical views on new techniques in genetic technology.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany genome editing market size, by technology, 2018-2030 (US$M)
Germany Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
